Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2220579rdf:typepubmed:Citationlld:pubmed
pubmed-article:2220579lifeskim:mentionsumls-concept:C1522565lld:lifeskim
pubmed-article:2220579lifeskim:mentionsumls-concept:C0042523lld:lifeskim
pubmed-article:2220579lifeskim:mentionsumls-concept:C0340288lld:lifeskim
pubmed-article:2220579lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:2220579lifeskim:mentionsumls-concept:C0035028lld:lifeskim
pubmed-article:2220579lifeskim:mentionsumls-concept:C0348016lld:lifeskim
pubmed-article:2220579pubmed:issue10lld:pubmed
pubmed-article:2220579pubmed:dateCreated1990-11-19lld:pubmed
pubmed-article:2220579pubmed:abstractTextLeft ventricular (LV) diastolic function is often impaired in coronary artery disease (CAD). To assess whether verapamil could improve LV diastolic properties, 12 patients with CAD undergoing right- and left-sided cardiac catheterization, as well as simultaneous radionuclide angiography, were studied before and during intravenous administration of verapamil (0.1 mg/kg as a bolus followed by 0.007 mg/kg/min). The heart rate was kept constant by atrial pacing in both studies. LV pressure-volume relations were obtained. Verapamil decreased LV systolic pressure (130 +/- 22 to 117 +/- 16 mm Hg, p less than 0.01) and the end-systolic pressure/volume ratio (2.4 +/- 1.3 to 1.6 +/- 0.5 mm Hg/ml, p less than 0.05), and increased LV end-diastolic (13 +/- 4 to 16 +/- 4 mm Hg, p less than 0.02) and pulmonary capillary pressures (10 +/- 5 to 12 +/- 5 mm Hg, p less than 0.005). Despite such negative inotropic effects, cardiac index increased (3.4 +/- 0.7 to 3.9 +/- 0.6 liters/min/m2, p less than 0.02). The time constant of isovolumic relaxation shortened (63 +/- 14 to 47 +/- 9 ms, p less than 0.02); peak filling rate increased (370 +/- 155 to 519 +/- 184 ml/s, p less than 0.001; 2.6 +/- 1.1 to 3.3 +/- 0.9 end-diastolic counts/s, p less than 0.02; and 4.1 +/- 1.6 to 5.5 +/- 1.5 stroke counts/s, p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:2220579pubmed:languageenglld:pubmed
pubmed-article:2220579pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2220579pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2220579pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2220579pubmed:statusMEDLINElld:pubmed
pubmed-article:2220579pubmed:monthOctlld:pubmed
pubmed-article:2220579pubmed:issn0002-9149lld:pubmed
pubmed-article:2220579pubmed:authorpubmed-author:PiscioneFFlld:pubmed
pubmed-article:2220579pubmed:authorpubmed-author:ChiarielloMMlld:pubmed
pubmed-article:2220579pubmed:authorpubmed-author:CondorelliMMlld:pubmed
pubmed-article:2220579pubmed:authorpubmed-author:AlfaniDDlld:pubmed
pubmed-article:2220579pubmed:authorpubmed-author:PaceLLlld:pubmed
pubmed-article:2220579pubmed:authorpubmed-author:BetocchiSSlld:pubmed
pubmed-article:2220579pubmed:authorpubmed-author:SalvatoreMMlld:pubmed
pubmed-article:2220579pubmed:authorpubmed-author:Perrone-Filar...lld:pubmed
pubmed-article:2220579pubmed:authorpubmed-author:Cappelli-Biga...lld:pubmed
pubmed-article:2220579pubmed:authorpubmed-author:CiarmielloAAlld:pubmed
pubmed-article:2220579pubmed:issnTypePrintlld:pubmed
pubmed-article:2220579pubmed:day1lld:pubmed
pubmed-article:2220579pubmed:volume66lld:pubmed
pubmed-article:2220579pubmed:ownerNLMlld:pubmed
pubmed-article:2220579pubmed:authorsCompleteYlld:pubmed
pubmed-article:2220579pubmed:pagination818-25lld:pubmed
pubmed-article:2220579pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2220579pubmed:meshHeadingpubmed-meshheading:2220579-...lld:pubmed
pubmed-article:2220579pubmed:meshHeadingpubmed-meshheading:2220579-...lld:pubmed
pubmed-article:2220579pubmed:meshHeadingpubmed-meshheading:2220579-...lld:pubmed
pubmed-article:2220579pubmed:meshHeadingpubmed-meshheading:2220579-...lld:pubmed
pubmed-article:2220579pubmed:meshHeadingpubmed-meshheading:2220579-...lld:pubmed
pubmed-article:2220579pubmed:meshHeadingpubmed-meshheading:2220579-...lld:pubmed
pubmed-article:2220579pubmed:meshHeadingpubmed-meshheading:2220579-...lld:pubmed
pubmed-article:2220579pubmed:meshHeadingpubmed-meshheading:2220579-...lld:pubmed
pubmed-article:2220579pubmed:meshHeadingpubmed-meshheading:2220579-...lld:pubmed
pubmed-article:2220579pubmed:meshHeadingpubmed-meshheading:2220579-...lld:pubmed
pubmed-article:2220579pubmed:meshHeadingpubmed-meshheading:2220579-...lld:pubmed
pubmed-article:2220579pubmed:meshHeadingpubmed-meshheading:2220579-...lld:pubmed
pubmed-article:2220579pubmed:meshHeadingpubmed-meshheading:2220579-...lld:pubmed
pubmed-article:2220579pubmed:year1990lld:pubmed
pubmed-article:2220579pubmed:articleTitleEffects of intravenous verapamil on left ventricular relaxation and filling in stable angina pectoris.lld:pubmed
pubmed-article:2220579pubmed:affiliationDepartment of Cardiology, Federico II University of Naples Second School of Medicine, Italy.lld:pubmed
pubmed-article:2220579pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2220579pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed